Blood absolute blast counts during days 1 to 10 of G3139 infusion.

The blood absolute blast counts for each patient are plotted with regard to days of treatment. Patients UPN 10 and UPN 14 were taken off the study before initiation of fludarabine/cytarabine at day 6 because of highly proliferative disease and symptoms of leukostasis requiring immediate treatment with leukapheresis and cytoreductive agents (ie, hydroxyurea). The total white blood cell (WBC) count trend was similar to that of the blast counts represented in the figure.